Εμφάνιση απλής εγγραφής

dc.creatorTsoucalas G., Chevallier J., Karamanou M., Papaioannou T., Sgantzos M., Androutsos G.en
dc.date.accessioned2023-01-31T10:18:01Z
dc.date.available2023-01-31T10:18:01Z
dc.date.issued2016
dc.identifier10.2174/1381612822666160111124615
dc.identifier.issn13816128
dc.identifier.urihttp://hdl.handle.net/11615/80110
dc.description.abstractThrombosis is a well known phenomenon among physicians since antiquity. A variety of peculiar agents, such as leeches and bark, were used to prevent it. Hirudin was used during the 19th century. The next eon, heparin, strepokinase, urokinase, TPA, dicumarol, warfarin, aspirin, ticlopidine, Clopidogrel, SSHA and SP54 provoked huge advances in anticoagulation. During 21st century with the use of fondaparinux, dabigatran, rivaroxaban and Ticagrelor antithrombotic prevention and therapeutic interaction entered an era of medical challenges. Although the risk after a thrombotic episode is now highly reduced, blood clots still present damaging or even lethal consequences in human organisms and further research is strongly recommended. © 2016 Bentham Science Publishers.en
dc.language.isoenen
dc.sourceCurrent Pharmaceutical Designen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84964240547&doi=10.2174%2f1381612822666160111124615&partnerID=40&md5=ce26ec0348affb209e8c2290b0210264
dc.subjectacetylsalicylic aciden
dc.subjectanticoagulant agenten
dc.subjectantithrombocytic agenten
dc.subjectclopidogrelen
dc.subjectdicoumarolen
dc.subjectheparinen
dc.subjecthirudinen
dc.subjectpentosan polysulfateen
dc.subjectstreptokinaseen
dc.subjectticagreloren
dc.subjectticlopidineen
dc.subjecturokinaseen
dc.subjectwarfarinen
dc.subjectanticoagulant agenten
dc.subjectantithrombocytic agenten
dc.subjectanticoagulationen
dc.subjectArticleen
dc.subjectbleeding disorderen
dc.subjectblood clottingen
dc.subjectdisease severityen
dc.subjectdrug acetylationen
dc.subjectfibrinolysisen
dc.subjecthumanen
dc.subjectnonhumanen
dc.subjectpriority journalen
dc.subjectthrombocyte functionen
dc.subjectthromboembolismen
dc.subjectthrombosisen
dc.subjectdrug effectsen
dc.subjecthistoryen
dc.subjectthrombosisen
dc.subjectAnticoagulantsen
dc.subjectBlood Coagulationen
dc.subjectHistory, 19th Centuryen
dc.subjectHistory, 20th Centuryen
dc.subjectHistory, 21st Centuryen
dc.subjectHumansen
dc.subjectPlatelet Aggregation Inhibitorsen
dc.subjectThrombosisen
dc.subjectBentham Science Publishers B.V.en
dc.titleHistorical hallmarks of anticoagulation and antiplatelet agentsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής